Retinopathy in old persons with and without diabetes mellitus: The Age, Gene/Environment Susceptibility-Reykjavik Study (AGES-R)

Diabetologia

Volumn 55, Issue 3, 2012, Pages 671-680

  Gunnlaugsdottir, E ^a,b   Halldorsdottir, S ^c   Klein, R ^d   Eiriksdottir, G ^c   Klein, B E ^d   Benediktsson, R ^a,b   Harris, T B ^e   Launer, L J ^e   Aspelund, T ^b,c   Gudnason, V ^b,c   Cotch, M F ^f   Jonasson, F ^a,b  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c ICELANDIC HEART ASSOCIATION   (Iceland)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e Demography and Biometry   (United States)

^f Division of Epidemiology and Clinical Applications   (United States)

Author keywords

Diabetes mellitus; Microalbuminuria; Non diabetic; Old age; Population sample; Random; Retinopathy

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG USE; EYE FUNDUS; EYE PHOTOGRAPHY; FEMALE; GENOTYPE ENVIRONMENT INTERACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREVALENCE; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINA MACULA EDEMA; RETINOPATHY; RISK FACTOR;

AGED; AGED, 80 AND OVER; AGING; ALBUMINURIA; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; ICELAND; MACULAR EDEMA; MALE; PREVALENCE; RETINA; RETINAL DISEASES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 84856698001     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-011-2395-y     Document Type: Article

References (35)

1. G Danaei MM Finucane Y Lu, et al. 2011 National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants Lancet 378 31 40 21705069 10.1016/S0140-6736(11)60679-X 1:CAS:528:DC%2BC3MXotlyltbo%3D
2. S Wild G Roglic A Green R Sicree H King 2004 Global prevalence of diabetes: estimates for the year 2000 and projections for 2030 Diabetes Care 27 1047 1053 15111519 10.2337/diacare.27.5.1047
3. World Health Organization (2006) Prevention of blindness from diabetes mellitus. Report of a WHO consultation. WHO, Geneva. http://whqlibdoc.who.int/ publications/2006/924154712x-eng.pdf. Accessed 13 May 2011
4. R Klein BE Klein SE Moss TY Wong 2006 The relationship of retinopathy in persons without diabetes to the 15-year incidence of diabetes and hypertension: Beaver Dam Eye Study Trans Am Ophthalmol Soc 104 98 107 17471330
5. E Ojaimi TT Nguyen R Klein, et al. 2011 Retinopathy signs in people without diabetes: the multi-ethnic study of atherosclerosis Ophthalmology 118 656 662 21055817 10.1016/j.ophtha.2010.08.007
6. S Cugati L Cikamatana JJ Wang A Kifley G Liew P Mitchell 2006 Five-year incidence and progression of vascular retinopathy in persons without diabetes: the Blue Mountains Eye Study Eye 20 1239 1245 16167076 10.1038/sj.eye.6702085 1:STN:280:DC%2BD28nlsVGruw%3D%3D
7. B Thorsson T Aspelund TB Harris LJ Launer V Gudnason 2009 Trends in body weight and diabetes in forty years in Iceland Laeknabladid 95 259 266 19420407
8. JK Kristinsson E Stefansson F Jonasson I Gislason S Bjornsson 1994 Screening for eye disease in type 2 diabetes mellitus Acta Ophthalmol (Copenh) 72 341 346 10.1111/j.1755-3768.1994.tb02770.x 1:STN:280:DyaK2M%2Fms1OltA%3D%3D
9. E Olafsdottir E Stefansson 2007 Biennial eye screening in patients with diabetes without retinopathy: 10-year experience Br J Ophthalmol 91 1599 1601 17627978 10.1136/bjo.2007.123810 1:STN:280:DC%2BD2snot1CqsQ%3D%3D
10. E Gunnlaugsdottir A Arnarsson F Jonasson 2008 Prevalence and causes of visual impairment and blindness in Icelanders aged 50 years and older: the Reykjavik Eye Study Acta Ophthalmol 86 778 785 18513265 10.1111/j.1755-3768. 2008.01191.x
11. E Gunnlaugsdottir A Arnarsson F Jonasson 2010 Five-year incidence of visual impairment and blindness in older Icelanders: the Reykjavik Eye Study Acta Ophthalmol 88 358 366 19222399
12. TB Harris LJ Launer G Eiriksdottir, et al. 2007 Age, gene/environment susceptibility-Reykjavik Study: multidisciplinary applied phenomics Am J Epidemiol 165 1076 1087 17351290 10.1093/aje/kwk115
13. F Jonasson A Arnarsson G Eiriksdottir, et al. 2011 Prevalence of age-related macular degeneration in old persons: age, gene/environment susceptibility-Reykjavik Study Ophthalmology 118 825 830 21126770 10.1016/j.ophtha.2010.08.044
14. C Qiu MF Cotch S Sigurdsson, et al. 2009 Microvascular lesions in the brain and retina: the age, gene/environment susceptibility-Reykjavik Study Ann Neurol 65 569 576 19475677 10.1002/ana.21614
15. World Health Organization (2011) Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. Abbreviated report of a WHO consultation. WHO/NMH/CPM/11.1 2011. WHO, Geneva
16. World Health Organization (1999) Expert Committee Definition dacodmaic. Report of a WHO consultation, part 1: diagnosis and classification of diabetes mellitus. WHO, Geneva
17. Association American Diabetes 2010 Diagnosis and classification of diabetes mellitus Diabetes Care 33 Suppl 1S 62 69 10.2337/dc10-S062
18. GR Warnick RH Knopp V Fitzpatrick L Branson 1990 Estimating low-density lipoprotein cholesterol by the Friedewald equation is adequate for classifying patients on the basis of nationally recommended cutpoints Clin Chem 36 15 19 2297909 1:STN:280:DyaK3c7isFSlsQ%3D%3D
19. E Olafsdottir T Aspelund G Sigurdsson, et al. 2011 Effects of statin medication on mortality risk associated with type 2 diabetes in older persons: the population-based AGES-Reykjavik Study BMJ Open 1 e000132 22021772 10.1136/bmjopen-2011-000132
20. Early Treatment Diabetic Retinopathy Study Research Group 1991 Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group Ophthalmology 98 786 806
21. R Klein MD Davis YL Magli P Segal BE Klein L Hubbard 1991 The Wisconsin age-related maculopathy grading system Ophthalmology 98 1128 1134 1843453 1:STN:280:DyaK3MzmslCrsQ%3D%3D
22. AS Levey JP Bosch JB Lewis T Greene N Rogers D Roth 1999 A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group Ann Intern Med 130 461 470 10075613 1:CAS:528:DyaK1MXitFChs7k%3D
23. TY Wong R Klein FM Islam, et al. 2006 Diabetic retinopathy in a multi-ethnic cohort in the United States Am J Ophthalmol 141 446 455 16490489 10.1016/j.ajo.2005.08.063
24. X Zhang JB Saaddine CF Chou, et al. 2010 Prevalence of diabetic retinopathy in the United States, 2005-2008 JAMA 304 649 656 20699456 10.1001/jama.2010.1111 1:CAS:528:DC%2BC3cXhtVelsbvE
25. R Klein BE Klein SE Moss KL Linton 1992 The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus Ophthalmology 99 58 62 1741141 1:STN:280:DyaK387lvVehtA%3D%3D
26. P Mitchell W Smith JJ Wang K Attebo 1998 Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study Ophthalmology 105 406 411 9499768 10.1016/S0161-6420(98)93019-6 1:STN:280:DyaK1c7mtVOntQ%3D%3D
27. R Klein BE Klein SE Moss MD Davis DL DeMets 1984 The Wisconsin Epidemiologic Study of Diabetic Retinopathy III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years Arch Ophthalmol 102 527 532 6367725 10.1001/archopht.1984.01040030405011 1:STN:280:DyaL2c7ltlCktg%3D%3D
28. R Varma GL Macias M Torres R Klein FY Pena SP Azen 2007 Biologic risk factors associated with diabetic retinopathy: the Los Angeles Latino Eye Study Ophthalmology 114 1332 1340 17306879 10.1016/j.ophtha.2006.10.023
29. R Klein BE Klein SE Moss KJ Cruickshanks 1994 Relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy Arch Intern Med 154 2169 2178 7944837 10.1001/archinte.1994.00420190068008 1:STN:280:DyaK2M%2FjtFGgtg%3D%3D
30. R Danielsen T Helgason F Jonasson 1983 Prognostic factors and retinopathy in type 1 diabetics in Iceland Acta Med Scand 213 323 326 6349260 10.1111/j.0954-6820.1983.tb03745.x 1:STN:280:DyaL3s3nvFWlsQ%3D%3D
31. TY Wong J Coresh R Klein, et al. 2004 Retinal microvascular abnormalities and renal dysfunction: the Atherosclerosis Risk in Communities Study J Am Soc Nephrol 15 2469 2476 15339997 10.1097/01.ASN.0000136133.28194.E4
32. C Qiu MF Cotch S Sigurdsson, et al. 2008 Retinal and cerebral microvascular signs and diabetes: the Age, Gene/Environment Susceptibility- Reykjavik Study Diabetes 57 1645 1650 18332097 10.2337/db07-1455 1:CAS:528:DC%2BD1cXnsF2is74%3D
33. N Cheung TY Wong 2008 Diabetic retinopathy and systemic vascular complications Prog Retin Eye Res 27 161 176 18249026 10.1016/j.preteyeres.2007. 12.001 1:CAS:528:DC%2BD1cXjtVCgtLw%3D
34. RJ Tapp G Tikellis TY Wong, et al. 2008 Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle Study Diabetes Care 31 1349 1354 18411241 10.2337/dc07-1707 1:CAS:528:DC%2BD1cXpt1Wrs7o%3D
35. EJ Gallagher D LeRoith ZT Bloomgarden 2009 Review of hemoglobin A(1c) in the management of diabetes J Diabetes 1 9 17 20923515 10.1111/j.1753-0407.2009. 00009.x 1:CAS:528:DC%2BC3cXksl2ksLY%3D